News

Matchmaking webinars Digital Europe calls

Published on | 1 year ago

Programmes AI Continent

The Dutch and the Danish Digital Europe NCPs are organising matchmaking webinars for three Digital Europe calls and extend their invitation to the Flemish stakeholders.

The following webinars are planned:

The programme for each of the webinars are the following:

  • Welcome
  • Pitch from a consortium
  • Pitches from registered actors
  • Open floor if time permits
  • Conclusions

If you wish to participate in this event, please send an email to digital.europe@rvo.nl at least one day before the event. If you register for this event, you agree to share your contact information with other participants and interested parties.

If you want to pitch your idea or organization at the webinars on the 22nd of March or the 4th of April, please send a request to digital.europe@rvo.nl.

Depending on the number of submissions, the organisers may need to make a limited selection.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1660 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.